Skip to main content
search

Certara is transforming drug development for good

Welcome to Certara. We transform drug development for the benefit of humans. Our commitment is to empower innovators, researchers, and regulatory experts with software and service solutions tailored exactly to meet their needs, fostering success across the entire drug development lifecycle.

Certara Mission & Vision

Certara is dedicated to transforming drug discovery and development for good. We harness the power of biosimulation, advanced analytics, scientific, strategic and regulatory expertise to create a future where treatments reach patients faster and more efficiently.

11,000
global users of our solutions
2,600
companies trust our software
33,000
peer-reviewed articles cite our products

Client-centric solutions that improve drug development

From molecule to market, we tailor solutions to meet our clients’ most pressing challenges. Through strategic leadership, scientific and regulatory rigor along with advanced predictive technologies, Certara provides comprehensive solutions to optimize drug development processes, reduce risks, and improve outcomes.

The keenest minds in life science and technology

With over 350 scientific consultants and industry experts, Certara’s voice in drug development is respected around the world. Our customers are located in over 70 countries.

Leaders in the science of life

Over millenia, nature dictated that you lost 5 of 7 children and died before you reached 50. Certara plays in one of the most important sectors: the application of science and technology to improve and extend human health and life.

Regulatory adoption

Certara works closely with global regulatory agencies to ensure compliance and streamline submission processes, accelerating submissions and enhancing patient access to better medicines and treatments.

Learn about regulatory adoption

Meet our leadership

Our leadership team brings unparalleled expertise and vision that drives Certara’s mission. With decades of experience in science, technology, and healthcare, we’re united in our goal to transform the drug development landscape.

Our leadership

Certara’s contribution to the drug development program for Nurtec ODT was substantial. Their clinical pharmacology representative worked seamlessly with the Biohaven Development Team. Certara’s considerable expertise in clinical pharmacology and pharmacometrics and flawless execution supported Nurtec’s clinical development team and helped to prepare the clinical pharmacology NDA components.

Richard Bertz, PhD
Vice President, Clinical Pharmacology & Pharmacometrics, Biohaven

Global presence

Our footprint extends across the globe, partnering with industry leaders and regulatory agencies to advance therapeutic innovation. From regulatory adoption to strategic partnerships, we’re at the heart of the scientific community.

Continuous investment in innovation

In 2008, Tripos International and Pharsight Corporation came together to form Certara. Since then, we have achieved incredible growth through acquisitions and the pharmaceutical industry and regulatory agencies’ adoption of model-informed drug development (MIDD).
Today, we are the global leader in biosimulation.

Integrating workflows to accelerate scientific insights from discovery to commercialization.
2025
Add biosimulation to Discovery. Add cheminformatics to address early failures.
2024
Industrializing QSP with the industry’s largest team; end to end clinical data automation utilizing meta data driven standards
2023
Scalable AI for life sciences with specialized generative pre-trained transformers (GPTs)
2022
Data pipeline and validation software
2021
US and global market access, pricing and contracting strategies
2019
Quantitive systems pharmacology (QSP) physiology
2020
eCTD publication and validation; submissions management software
2017
Value communication software, extendible pharmacometrics workbench, RWE prediction, value assessment, and data analysis
2018
Strategic drug development leveraging modeling and simulation technology, and regulatory advisory and communications expertise
2016
Quantitive modeling and clinical trial outcomes databases to leverage publicly- available clinical trial data: Mechanistic pharmacology for precision medicine
2015
Pre-clinical, clinical, CMC and drug safety writing, and global regulatory submission services
2014
Clinical pharmacology development support; PK, PD, and biostatistical analysis & reporting
2013
PBPK Modeling for in silico research with virtual patient populations
2012
Scientific computational drug discovery (est. 1979) merges with Data for PK/PD modeling, analysis and simulation (est. 1995)
2008

Certara’s responsibility

We’re committed to sustainable practices, ethical business, and making a positive impact on global health. Our responsibility extends to patients, partners, and the planet, ensuring that every solution we deliver aligns with our core values.

Discover more about Certara

Strategic partnership

Collaboration is key to our success. Certara’s network of partners spans academia, industry, and government, driving innovation and expanding possibilities in drug development.

Become a partner

Investing in Innovation

Certara is at the forefront of transforming drug development, delivering exceptional value to stakeholders and shaping the future of healthcare. Explore how our strategic vision and innovative solutions drive sustainable growth and success.

Visit investors site

Shape the Future of Drug Development

Certara is recognized as an ethical, inclusive and responsible employer. You’ll find inspiring and engaged people at our workplaces. Do you want to be one of us? We invite you to apply.

Visit careers site